Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy (Q38907088)

7 September 2017

title

Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy (English)

1 reference

adaptive radiation therapy

7 September 2017

main subject

0 references

1 reference

1 reference

Beyer DC

1 reference

7 September 2017

Brachman DG

series ordinal

1 reference

7 September 2017

publication date

1 December 2000

1 reference

Radiotherapy and Oncology

7 September 2017

published in

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

263-267

1 reference

Biochemical disease-free survival following 125I prostate implantation

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900286-3

7 January 2021

10.1016/S0167-8140(00)00286-3

Identifiers

DOI

1 reference

7 September 2017

1 reference